Schellack, Carola <br/><br/>
IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses.  [electronic resource] 

 -  Vaccine  Jun 2006 
 - 5461-72 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0264-410X 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2006.03.071  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--metabolism<br/>Adjuvants, Immunologic--pharmacology<br/>Animals<br/>Cell Differentiation<br/>Cell Proliferation<br/>Dendritic Cells--drug effects<br/>Dose-Response Relationship, Drug<br/>Mice<br/>Mice, Inbred C57BL<br/>Myeloid Differentiation Factor 88<br/>Ovalbumin--immunology<br/>Signal Transduction--physiology<br/>T-Lymphocytes--drug effects<br/>Toll-Like Receptor 9--metabolism